A Study to Compare the Pharmacokinetics of YM150 Formulation-A and Formulation-B

Inclusion Criteria: * Body weight: ≥50.0 kg, \<80.0 kg * BMI: ≥17.6, \<26.4 * Healthy, as judged by the investigator or sub-investigator based on the results of physical examinations and lab tests Exclusion Criteria: * Received any investigational drugs within 120 days before the study * Donated 400 mL of whole blood within 90 days, 200 mL of whole blood within 30 days, or blood components within 14 days before the study * Received medication within 7 days before the study * A deviation from the assessment criteria of physical examinations or laboratory tests * A deviation from the normal reference range of coagulation test \[PT (INR) or aPTT\] * History of drug allergies * Upper gastrointestinal disease within 7 days before the study * Concurrent or previous hepatic, gastrointestinal, heart, cerebrovascular or respiratory diseases * Concurrent or previous malignant tumor * Previous treatment with YM150